PMC4891615_01
Axial CT demonstrating patchy, nonspecific ground glass opacities (arrows) in a patient who had started thalidomide therapy for multiple myeloma three weeks prior. [Powerpoint Slide]
gr1.jpg
PMC4891615_01_gr1.jpg
fig1
A CT scan of the chest was performed demonstrating nonspecific scattered ground glass opacities (Figure 1).
Coronal reformat (a) and axial (b) CT, performed three weeks after the CT shown in Figure 1, shows interval worsening of ground glass opacities (arrows). Thalidomide therapy was discontinued at this time. [Powerpoint Slide]
gr2.jpg
PMC4891615_01_gr2.jpg
fig2
A CT scan of the chest (Figure 2) demonstrated extensive ground-glass attenuation throughout both lungs, which had significantly worsened since the previous CT scan.
Axial CT obtained one month after discontinuation of thalidomide therapy demonstrates near complete resolution of pulmonary opacities. [Powerpoint Slide]
gr3.jpg
PMC4891615_01_gr3.jpg
fig3
One month after discharge a repeat CT scan was performed, revealing near resolution of the pulmonary opacities (Figure 3).